HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01
HORIZON-JU-GH-EDCTP3-2022-CALL1-01-01
Programme: Horizon Europe
11 projects · €46,393,348 total EU contribution (project-level) · 69 participating organizations · 26 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€46,393,348
Countries active
Participant organizations by country (headquarters in CORDIS).
- France (9)
- UK (8)
- ZA (6)
- UG (4)
- ZM (4)
- BE (3)
- CD (3)
- CH (3)
- Germany (3)
- Spain (3)
- MZ (3)
- Netherlands (3)
- TZ (3)
- NO (2)
- AU (1)
- BF (1)
- BI (1)
- BJ (1)
- GH (1)
- Italy (1)
- KE (1)
- MG (1)
- MW (1)
- RW (1)
- SE (1)
- ZW (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- IRD3 projects · FR
- KEMRI2 projects · KE
- LSTM2 projects · UK
- MOH2 projects · ZM
- UOXF2 projects · UK
- UNZA2 projects · ZM
- Leiden University Medical Center1 projects · NL
- ADERA1 projects · FR
- AFRICA HEALTH RESEARCH INSTITUTE (AHRI)1 projects · ZA
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- BRTI1 projects · ZW
- Bridges to Development1 projects · CH
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
EPiTB: Addressing an unmet need: same day diagnosis of extra-pulmonary TB in a high burden setting. EPiTB · 101103281 | HORIZON | €3,989,909 | €521,275 | Details |
Validation of treatment decision algorithms for childhood tuberculosis at low levels of healthcare in high burden countries - effectiveness, implementation, and integration into policy and practices Decide-TB · 101103283 | HORIZON | €5,299,965 | €208,594 | Details |
Implementation of an upgraded strategy to reach zero HIV transmission by breastfeeding in rural and urban settings in Zambia – the PROMISE-ZERO study PROMISE-ZERO · 101103295 | HORIZON | €3,995,300 | €274,950 | Details |
Implementation of superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa NeuroSolve · 101103306 | HORIZON | €4,234,052 | €597,890 | Details |
STOP 2030: TOWARDS THE INTERRUPTION OF TRANSMISSION OF SOIL-TRANSMITTED HELMINTHS: PROMOTING IMPLEMENTATION OF RESEARCH RESULTS OF A FIXED-DOSE COMBINATION OF CO-FORMULATED IVERMECTIN AND ALBENDAZOLE STOP2030 · 101103089 | HORIZON | €3,553,502 | €821,394 | Details |
SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings] SEMA ReACT · 101103191 | HORIZON | €3,984,316 | €0 | Details |
Post-discharge malaria chemoprevention in children with severe anaemia in Benin, Kenya, Malawi and Uganda: Formative and implementation research for policy decision making and implementation PDMC Saves Lives · 101103078 | HORIZON | €4,531,137 | €1,105,029 | Details |
Implementing oral and long acting Pre-exposure prophylaxis in mobile men in Sub-Saharan Africa [MOBILE MEN] MOBILE MEN · 101103140 | HORIZON | €4,665,193 | €569,141 | Details |
Stop transmission of gambiense human African trypanosomiasis STROGHAT · 101103189 | HORIZON | €4,001,936 | €2,306,436 | Details |
Implementing Primaquine Single Low Dose in Africa IMPRIMA · 101103213 | HORIZON | €3,967,406 | €609,268 | Details |